03 Profile
Hansard to 9 November 2026 · 31,243 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Heart disease & stroke
Mike Sharma
trial's principal investigator
press citations on 1 topic since 17 Apr 2026 · last quoted 20 Apr 2026
02 Quoted on · 1 of 29 topics
Mike Sharma: key facts
- Kind of voice
- Academic
- Role
- trial's principal investigator
- Quoted on
- Heart disease & stroke
- Tracked press citations
- 2
- Most recently quoted
- 20 Apr 2026
- First quoted
- 17 Apr 2026
04 The signal · where Mike Sharma sits on heart disease & stroke
Ranked 18= of 100 voices quoted in the press on heart disease & stroke, level with 26 others on 2 citations.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1
Dr Sonya Babu-NarayanClinicianClinical Director, British Heart Foundation7 - 2=
Professor Azeem MajeedAcademicProfessor of Primary Care and Public Health and Head of the Department of Primary Care and Public Health, Imperial College London6 - 2=
Professor Bryan WilliamsSector leaderChief Scientific and Medical Officer, British Heart Foundation (BHF)6 - 18=Professor Ahmet FuatClinicianhonorary professor of primary care cardiology at Durham University and GP with extended role in cardiorenal medicine2
- 18=Prof Dan AugustineCliniciancardiologist at the National Heart Clinic, RUH Bath and the medical director of Sports Cardiology UK2
- 18=Mike SharmaAcademictrial's principal investigator2
- 18=Dr Sanjeev NayakClinicianConsultant Interventional Neuroradiologist, University Hospitals of North Midlands NHS Trust2
- 18=Dr. Karen Joynt MaddoxAcademiccardiologist, chair of the group that wrote the paper, professor of medicine and public health at the Washington University School of Medicine in St. Louis2
Showing the leaders and the ranks around 18=, of 100 voices · See every voice on the topic →
05 On the record · press
What Mike Sharma has said
- nrtimes.co.uk1
- pharmaceutical-journal.com1
Where Mike Sharma has been quoted
- 01Investigational anti-clotting drug reduced stroke risk by more than one-quarter, study findspharmaceutical-journal.com · 20 Apr 2026
- 02New drug lowers stroke risk without added bleeding, study findsnrtimes.co.uk · 17 Apr 2026
Verbatim
“This is something researchers have been working toward for decades. This trial marks a major step toward safer and more effective long-term treatment for stroke prevention.”
“Asundexian reduced the occurrence of a stroke by 26 per cent, and this benefit was consistent across patients of different ages, sexes, stroke severity, and stroke causes, without increasing major bleeding or other serious side effects.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.